The FDA issued approval for Antares Pharma's (Ewing, New Jersey) needle-free injection device for use with human growth hormone. The device will be marketed under the name Tev-Tropin Tjet Injector system.This reusable needle-free injector can deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. These reusable, variable-dose devices are engineered to last for a minimum of two years and are designed for easy use, facilitating self-injection with a disposable plastic needle-free syringe to assure safety and efficacy.
No comments:
Post a Comment